Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Louzanne to represent South Africa at World Championship
2015-10-26


Louzanne making a leap for the finish line with guide runner Rouxné Vermaak

Within the space of seven days, Louzanne Coetzee will take part in both the 1500m and 800m events at the International Paralympic Committee (IPC) Athletics World Championships, being held in Doha, Qatar, from 21-31 October 2015.

The BA Corporate and Marketing Communication Honours student at the University of the Free State (UFS) was selected to represent South Africa (SA) by the South African Sports Confederation and Olympic Committee (SASCOC). Team SA consists of 23 top athletes, who will be competing in different codes against 89 other countries.

The middle- and long-distance T11/F11 class athlete has won countless medals since her debut in professional athletics in 2012. After only five months, she reached the qualifying standard for international participation, with an impressive 2 minutes 53.8 seconds in the 800m at the 2013 Nedbank National Championships for the Physically Disabled, held in Pretoria.

Louzanne has since achieved another international milestone by making the SA team, following her inaugural IPC meeting, hosted by France two years ago.  

 

“It’s a big honour for me to represent South Africa, and I count myself very fortunate to represent the country at the World Champs,” said the former Accessibility and Student Support Student Representative Council (SRC) member.

 

The IPC World Championships precede the Rio 2016 Paralympic Games, which are known as “the biggest sporting event on the planet”. Qatar is Louzanne’s Rio, and she intends to outdo her personal best in order to qualify. “I want to get my ranking high enough so that I can go to Rio in 2016,” said the gold medallist.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept